Klein Joseph III's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Apr 2, 2026
- Accession no.
- 0000874015-26-000161
- Filed
- Apr 2, 2026
- Trade date
- Apr 1, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.69M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klein Joseph IIICIK 0001206369 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | MOption exerciseAcquired | +12,000 | $38.06 | +$456,720 | 23,014 | Direct | |
| Apr 1, 2026 | Common Stock | MOption exerciseAcquired | +10,321 | $41.08 | +$423,986.68 | 33,335 | Direct | |
| Apr 1, 2026 | Common Stock | SSaleDisposed | −20,105 | $75.50 | −$1,517,927.5 | 13,230 | Direct | |
| Apr 1, 2026 | Common Stock | SSaleDisposed | −2,216 | $75.95 | −$168,305.2 | 11,014 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | MOption exerciseDisposed | −12,000 | $0.00 | $0 | 0 | Direct | |
| Apr 1, 2026 | Common Stock | MOption exerciseDisposed | −10,321 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.